Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The point-of-care testing (POCT) market is rapidly evolving as healthcare systems worldwide seek faster, more accessible diagnostic solutions. With technological advances and shifting healthcare delivery models, this sector is poised for significant expansion. Let’s explore the current market size, key growth drivers, segmentation, emerging trends, main competitors, and regional dynamics shaping the POCT industry.

Current Market Size and Projected Growth Trajectory for the POCT Market

The POCT market has witnessed swift development over recent years. Its valuation is projected to rise from $50.79 billion in 2025 to $56.68 billion in 2026, marking a compound annual growth rate (CAGR) of 11.6%. This growth during the historical period results from increasing chronic disease rates, the urgent need for quick clinical decisions, expansion in emergency and critical care services, limited access to centralized labs, and the demand for immediate diagnostic results. Moving forward, the market is expected to surge further, reaching $86.91 billion by 2030, with a CAGR of 11.3%. Factors driving this forecasted growth include ongoing miniaturization of POCT devices, the rise of home care and remote patient monitoring, frequent outbreaks of infectious diseases, decentralization of healthcare, and wider adoption of self-testing diagnostics. Key trends anticipated during this period comprise greater use of rapid diagnostic testing at the point of care, rising consumer preference for home-based and self-testing options, expansion of over-the-counter diagnostic products, increased focus on early disease detection and screening, and improvements in the accuracy and sensitivity of POCT devices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

The Role of Telemedicine in Boosting Demand for POCT

One of the strongest drivers of POCT market growth is the expanding adoption of telemedicine services. Telemedicine involves delivering healthcare remotely through digital platforms such as video conferencing, phone calls, or secure messaging. The COVID-19 pandemic accelerated the acceptance of telemedicine by emphasizing the need for convenient, timely, and contactless care options. POCT complements telemedicine by enabling rapid and reliable diagnostic results that can be instantly shared with healthcare providers located remotely. For example, data from the American Hospital Association indicated that in 2023, over 12.6% of Medicare beneficiaries in the US used telehealth services. Moreover, projections show that by 2036, the physician workforce in the country could reach approximately 86,000, with telehealth playing a crucial role in alleviating healthcare provider shortages. This growing reliance on telemedicine is thus a key factor propelling the expansion of the POCT market.

Segments and Structure within the Point-of-Care Testing Market

The POCT market is systematically divided into several main segments:

1) Type of Test: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas or Electrolytes Testing, Urinalysis Testing, and Other Types

2) Mode of Purchase: Over-the-Counter Products and Prescribed Products

3) Technology Utilized: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, and Biochemical Testing

4) End-User Categories: Clinical Laboratories, Ambulatory Care Facilities and Physician Offices, Pharmacies, Retail Clinics and E-Commerce Platforms, Hospitals, Critical Care Centers, Urgent Care Centers, Home Care and Self-Testing, and Other End-Users

Access The Complete Point-Of-Care-Testing (POCT) Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Further breakdowns include subcategories such as:

– Blood Glucose Testing: Self-Monitoring Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

– Infectious Diseases Testing: HIV, Hepatitis, Influenza, COVID-19, and other infections

– Cardiac Markers Testing: Troponin, CK-MB, Myoglobin, BNP tests

– Coagulation Testing: Prothrombin Time, Activated Partial Thromboplastin Time, International Normalized Ratio

– Pregnancy and Fertility Testing: Pregnancy test kits, Ovulation test kits, Fertility hormone tests

– Blood Gas or Electrolytes Testing: Arterial and Venous blood gas tests, Electrolyte tests

– Urinalysis Testing: Urine chemistry analysis, Microscopic examination, Culture testing

– Other Types: Drug abuse, Allergy, Cholesterol, Thyroid function tests

Advancements and Technological Innovations Influencing POCT Growth

Leading players in the POCT market are channeling resources into cutting-edge technologies to meet the increasing desire for faster, clinic-level diagnostics. A prominent example is microfluidic rapid antimicrobial susceptibility testing (AST) systems, which use tiny fluid channels to culture and detect bacteria from patient samples such as urine. These systems can determine antibiotic susceptibility much faster than traditional culture methods that take days to yield results. For instance, in June 2023, Japan-based Sysmex Corporation launched the PA 100 AST System, a compact POCT analyzer that employs proprietary microfluidic cartridges to detect bacteria in roughly 15 minutes and deliver complete antimicrobial susceptibility results in about 30 minutes. This user-friendly device requires minimal training, as healthcare workers simply load the sample into a cartridge and insert it into the analyzer for automated results. The quick turnaround enables timely antibiotic treatment decisions during the initial patient consultation, helping reduce inappropriate prescriptions and combat antimicrobial resistance.

Key Companies Leading the Point-of-Care Testing Market

The POCT market features several prominent companies that shape the competitive landscape. These include Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, and Meridian Bioscience.

Regional Market Insights and Growth Patterns

In 2025, North America held the largest share of the POCT market. However, the Asia-Pacific region is anticipated to experience the fastest growth throughout the forecast period. The report analyzes various regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a broad perspective on global market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model